New drugs for multiple sclerosis

06 January 2015

Interview with 

Anne la Flamme, Malaghan Institute of Medical Research, Wellington

MS_Brain_treated.png

Risperidone treatment significantly reduces microglial activation in the CNS of mice with an MS-like disease. Image: Anne la Flamme, PLoS One, 2014.

Share

Multiple sclerosis is a condition caused by immune cells attacking parts of the nervous system. New Zealand has one of the highest incidences of the disease in the world. Dr Anne La Flamme is based at Wellington's Malaghan Institute of Medical Research where she's trying to understand why, and working on new ways to treat the disease, as she explains to Chris Smith...

Comments

Add a comment